Evidence map›Paper›PMID 27941804›Full record

ArticleActa pharmacologica Sinica2017

Resveratrol rescues hyperglycemia-induced endothelial dysfunction via activation of Akt.

Jin-Yi Li, Wei-Qiang Huang, Rong-Hui Tu, Guo-Qiang Zhong, Bei-Bei Luo, Yan He

RetractedOpen access · bronzeAbstract readRetracted Publication
In one paragraph

Article in Acta pharmacologica Sinica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Nutraceuticals as a potential adjunct therapy toward improving vascular health in CKD.American journal of physiology. Regulatory, integrative and comparative physiology · 2019
    Review
  7. Article
  8. Article
  9. Article
  10. mRNAs expression profiles of high glucose-induced memory in human umbilical vein endothelial cells.Diabetes, metabolic syndrome and obesity : targets and therapy · 2019
    Article
  11. Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jin-Yi LiDepartment of Aging, the First Hospital Affiliated to Guangxi Medical University, Nanning 530021, China.
Wei-Qiang HuangDepartment of Aging, the First Hospital Affiliated to Guangxi Medical University, Nanning 530021, China.
Rong-Hui TuDepartment of Aging, the First Hospital Affiliated to Guangxi Medical University, Nanning 530021, China.
Guo-Qiang ZhongDepartment of Aging, the First Hospital Affiliated to Guangxi Medical University, Nanning 530021, China.
Bei-Bei LuoDepartment of Aging, the First Hospital Affiliated to Guangxi Medical University, Nanning 530021, China.
Yan HeDepartment of Aging, the First Hospital Affiliated to Guangxi Medical University, Nanning 530021, China.
First Affiliated Hospital of GuangXi Medical University · CNGuangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resveratrol (RSV), a phytoalexin, has shown to prevent endothelial dysfunction and reduce diabetic vascular complications and the risk of cardiovascular diseases. The aim of this study was to investigate the signaling mechanisms underlying the protecting effects of RSV against endothelial dysfunction during hyperglycemia in vitro and in vivo. Human umbilical vein endothelial cells (HUVECs) were treated with RSV, and then exposed to high glucose (HG, 30 mmol/L). Akt-Ser473 phosphorylation, eNOS-Ser1177 phosphorylation, and PTEN protein levels in the cells were detected using Western blot. For in vivo studies, WT and Akt

Indexed as

AcetylcholineAnimalsCells, CulturedDose-Response Relationship, DrugEndothelium, VascularEnzyme ActivationGlucoseHumansHuman Umbilical Vein Endothelial CellsHyperglycemiaMiceMice, KnockoutNitric Oxide Synthase Type IIIPhosphorylationProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseAcetylcholineGlucoseNitric Oxide Synthase Type IIINos3 protein, mouseProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseResveratrolRNA, Small InterferingStilbenes

Identifiers

PMID27941804
PMCPMC5309750
OpenAlexW2565524872

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.